Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

SPECT Imaging with 99mTc-Tetrofosmin Research Imaging

This is an observational study; patients will be managed according to the standard clinical care of the local site. Study end will be defined as completion of all SPECT imaging at rest and stress. Studies will be acquired at 6 initial sites with mixed prior experience at MBF imaging, to demonstrate feasibility of use in a clinical setting.

Trial Locations (7)

169609

National Heart Center Singapore, Singapore

Unknown

Universitaire ziekenhuizen Leuven, Leuven

London Health Sciences Centre, London

Medizinische Hochschule Hannover, Hanover

Nuclear Medicine, Università & Spedali Civili, Brescia, Italy, Brescia

Ehime University Hospital, Tōon

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER